Ranking · Summer 2022 · Healthcare · Diagnostics

Signatur Biosciences

Simple tests for complex diseases.

3.9%

odds of being acquired in the next two years

0.6× the average (6.8%)

#4133 of 4,339 active YC companies · top 96%

Team of 5 · London, England, United Kingdom

Raises the odds

↑ team of 3–5

↑ based in Remote

Lowers the odds

↓ industry: Healthcare

↓ tag: Healthcare

↓ tag: Biotech

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Signatur Biosciences's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

signatur.bio YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub